Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Graham R. Baker"'
Autor:
Lucy H. Elliot, Pitt Gary Robert William, Franklin Richard Jeremy, Doreen M. Ashworth, Michael Szelke, Satoshi Yamamoto, Andrew John Baxter, Graham R. Baker, D.Michael Evans, Andrew Sheppard, David W.M. Benzies, Graeme Semple, Rooker David Philip, Peter Hudson, Paul D. Jenkins, Andrzej Roman Batt, Yasuo Isomura
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:1337-1342
New potent, reversible inhibitors of recombinant human Interleukin-1β-converting enzyme (ICE, caspase-1) with significantly reduced peptide character are described. The compounds were designed by incorporation of pyridone and pyrimidone heterocyclic
Autor:
Paul D. Jenkins, Michael Szelke, Andrew John Baxter, Graham R. Baker, D. Michael Jones, Butrus Atrash, Doreen M. Ashworth
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:2745-2748
A series of stable, very potent inhibitors of dipeptidyl peptidase IV has been developed. A number of dipeptide analogues, incorporating a 4-cyanothiazolidide, were found to have Ki values of less than 1 nM versus human DP-IV and half-lives of betwee
Autor:
Butrus Atrash, Paul D. Jenkins, Andrew John Baxter, Doreen M. Ashworth, D. Michael Jones, Michael Szelke, Graham R. Baker
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:1163-1166
A novel series of stable, potent inhibitors of dipeptidyl peptidase IV has been developed. A number of dipeptide analogues, incorporating a 2-cyanopyrrolidide, were found to have K i values of less than 5 nM versus human DP-IV and half-lives of >48h
Publikováno v:
ChemInform. 23
D- and L- myo -inositol 1-phosphorothioate have been synthesized from 2,3,4,5,6- O -pentabenzyl- myo -inositol. Both enantiomers are slow substrates for inositol monophosphatase and weak competitive inhibitors, therefore, ideal probes for the phospha
Autor:
D. M. Jones, Doreen M. Ashworth, Paul D. Jenkins, Andrew John Baxter, Michael Szelke, Graham R. Baker, Butrus Atrash
Publikováno v:
ChemInform. 27
Autor:
Andrew John Baxter, Butrus Atrash, Doreen M. Ashworth, Paul D. Jenkins, Michael Szelke, Graham R. Baker, D. M. Jones
Publikováno v:
ChemInform. 28
Autor:
Y. Isomura, Lucy H. Elliot, Andrew John Baxter, Peter Hudson, S. Yamamoto, Paul D. Jenkins, Andrzej Roman Batt, Doreen M. Ashworth, Graeme Semple, Andrew Sheppard, Michael Szelke, Graham R. Baker, Pitt Gary Robert William, David Michael Evans, David W.M. Benzies, Franklin Richard Jeremy, Rooker David Philip
Publikováno v:
ChemInform. 28
Autor:
Graham R. Baker, David Gani
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 1:193-196
Inositol monophosphatase is unable to catalyse the exchange of 18O-label from 18O-water into inorganic phosphate in the absence of inositol. The inositol mediated exchange reaction is Mg2+ dependent, shows a similar pH dependence to that for the hydr
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 1:17-20
D- and L- myo -inositol 1-phosphorothioate have been synthesized from 2,3,4,5,6- O -pentabenzyl- myo -inositol. Both enantiomers are slow substrates for inositol monophosphatase and weak competitive inhibitors, therefore, ideal probes for the phospha
Publikováno v:
European journal of biochemistry. 212(3)
Lithium-sensitive inositol monophosphatase from bovine brain was purified from brain and from a recombinant strain of Escherichia coli BL21-DE3. The natural and recombinant enzymes displayed identical physical and kinetic properties. At low [Li+], Li